Paliperidone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

43 API Suppliers, 26 USDMF, 7 EU WC, 3 KDMF, 13 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

22 Drugs in Development

22 Drugs in Development

INTERMEDIATES

20 Intermediate Suppliers

20 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

425 FDF Dossiers, 60 FDA Orange Book, 307 Europe, 3 Canada, 14 Australia, 7 South Africa, 34 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 3MG, TABLET, EXTENDED RELEASE;ORAL - 6MG, TABLET, EXTENDED RELEASE;ORAL - 9MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 SPI Pharma, 13 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Kirsch Pharma, 1 Panvo Organics, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 22 BASF, 1 CD Formulation, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Esteem Industries, 2 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 20 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 4 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 22 Controlled & Modified Release, 16 Granulation, 14 Solubilizers, 14 Topical, 13 Thickeners and Stabilizers, 13 Lubricants & Glidants, 12 Film Formers & Plasticizers, 11 Direct Compression, 8 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 5 Emulsifying Agents, 4 Disintegrants & Superdisintegrants, 4 Vegetarian Capsules, 3 Co-Processed Excipients, 3 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 2 Taste Masking

DIGITAL CONTENT

33 News #PharmaBuzz

33 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 20 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

11 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 Health Canada Patents

5 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 3 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ Xls

Filters

FILTER :

filter Company Reset all filters

20 All

01 7JANSSEN CILAG INTERNAT.N.V.

02 4JANSSEN CILAG INTERNATIONAL NV

03 3KRKA DDNOVO MESTO

04 3SANDOZ SPA

05 3TEVA BV

filter Country Reset all filters

01

Brand Name : INVEGA

Switzerland

Cosmoprof

Not Confirmed

02

Brand Name : INVEGA

Switzerland

Cosmoprof

Not Confirmed

03

Brand Name : INVEGA

Switzerland

Cosmoprof

Not Confirmed

04

Brand Name : INVEGA

Switzerland

Cosmoprof

Not Confirmed

05

Brand Name : PALIPERIDON KRKA

Slovenia

Cosmoprof

Not Confirmed

06

Brand Name : PALIPERIDON KRKA

Slovenia

Cosmoprof

Not Confirmed

07

Brand Name : PALIPERIDON KRKA

Slovenia

Cosmoprof

Not Confirmed

08

Brand Name : PALIPERIDONE SANDOZ

Switzerland

Cosmoprof

Not Confirmed

09

Brand Name : PALIPERIDONE SANDOZ

Switzerland

Cosmoprof

Not Confirmed

10

Brand Name : PALIPERIDONE SANDOZ

Switzerland

Cosmoprof

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Paliperidone

Paliperidone

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

43 API Suppliers

26 USDMF

7 EU WC

3 KDMF

13 NDC API

23 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

22 Drugs in Development

INTERMEDIATES

20 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

425 FDF Dossiers

60 FDA Orange Book

307 Europe

3 Canada

14 Australia

7 South Africa

34 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 3MG

TABLET, EXTENDED RELEASE;ORAL - 6MG

TABLET, EXTENDED RELEASE;ORAL - 9MG

RELATED EXCIPIENT COMPANIES

1 Minakem

1 SPI Pharma

13 DKSH

1 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Kirsch Pharma

1 Panvo Organics

1 ACG Worldwide

5 Actylis

1 Aeon Procare

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

22 BASF

1 CD Formulation

10 Corel Pharma Chem

2 DFE Pharma

1 Esteem Industries

2 Finar

6 Gangwal Chemicals

4 Ideal Cures

20 Kerry

3 Kima Chemical

6 Lonza Capsugel

6 Microlex e.U

1 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

2 Pharmatrans-Sanaq

2 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

4 Roquette

6 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Sigachi Industries

2 The Dow Chemical Company

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Coating Systems & Additives

30 Fillers, Diluents & Binders

22 Controlled & Modified Release

16 Granulation

14 Solubilizers

14 Topical

13 Thickeners and Stabilizers

13 Lubricants & Glidants

TABLET, EXTENDED RELEASE;ORAL - 1.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 12MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons